Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-24

FDA Approved: VIRACEPT — Supplemental Application (AGOURON)

View source ↗

Summary

FDA approved a supplemental application for VIRACEPT (nelfinavir mesylate) from Agouron.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viracept (Nelfinavir)

Snippet

SUPPL AP for VIRACEPT (NELFINAVIR MESYLATE)